The ‘AI Gold Rush’ has officially hit Southern California as Takeda Pharmaceutical commits over $1.7 billion to a multi-year partnership with San Diego’s own Iambic Therapeutics. This high-stakes deal focuses …
San DiegoAmericasArtificial Intelligence and RoboticsBreaking NewsBusinessBusiness and Finance USACaliforniaCorporateEconomy and TradeGeneralGlobal Breaking NewsHealthLocal Breaking NewsMedical Advances and ResearchResearch and DiscoveriesTechnologyTodays HeadlinesWorld
San Diego’s $1.7B Tech-Bio Explosion: Takeda and Iambic’s AI Drug Deal Shakes the Industry
How a Local Biotech Startup is Using Proprietary AI to Outpace Big Pharma’s Traditional R&D
